MSB 3.21% $1.13 mesoblast limited

Cell Therapy News/Articles, page-9304

  1. 15,643 Posts.
    lightbulb Created with Sketch. 5711
    The phase 3 trial was stopped at its 2nd futility review

    Hilarious ... if you are going to come here to down ramp at least post facts to back up your agenda .... .... another false claim ... lol
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.